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Paragangliomas and phaeochromocytomas are exceptional
rare tumours in children arising from the neural crest ori-
gin. A number of susceptibility genes have been identified
to be associated with familial cases of paragangliomas and
phaeochromocytomas. Malignancy frequency has been
found to be high especially in patients with succinate
dehydrogenase subunit B (SDHB) mutations. We report a
case of a 13-year old Chinese girl with right adrenal
phaeochromocytoma, paraganglioma in the subhepatic
region with invasion into the inferior vena cava, and
metastases to the right scapula and vertex. She underwent
surgery for excision of the abdominal tumours, and also
therapeutic I-131-meta-iodobenzylguanidine (131-I-
MIBG) therapy for the metastatic lesions. She required a
left adrenalectomy 2 years later due to the occurrence of a
left phaeochromocytoma. She remained asymptomatic for
8 years after the initial presentation and is currently alive.
Although she does not have any family history of neuroen-
docrine tumours, susceptibility genes were screened in
view of the young age at presentation and multifocal
malignant tumours. She was found to carry a known
mutation c.572G>A (p.Cys191Tyr) in the SDHB gene.
This case illustrates the need for screening of susceptibility
genes for familial paragangliomas/phaeochromocytomas in
apparently sporadic cases, and the therapeutic benefit of
using 131-I-MIBG as an adjuvant treatment for metastatic
lesions.
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